Patents by Inventor David Ingram

David Ingram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11408554
    Abstract: A gantry-type positioning device includes first and second cross members. Two linear guides are disposed parallel to each other on a base and support the first and second cross members such that the cross members are movable in a first direction. A Y-carriage has a functional element and is supported on the first cross member such that the Y-carriage and the functional element are movable in a second direction. A position-measuring device is disposed on the second cross member and the Y-carriage such that a position of the Y-carriage relative to the second cross member is detectable. A Z-carriage supports the functional element such that the functional element is movable relative to the Y-carriage in a third direction. A further position-measuring device is disposed on the Y-carriage and the functional element such that a position of the functional element relative to the Y-carriage is detectable.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: August 9, 2022
    Assignee: ETEL S.A.
    Inventors: David Ingram, Laurent Heiniger
  • Patent number: 11033655
    Abstract: Stabilized monomer and polymer adhesive compositions useful in the formulation of biomedical adhesives and sealants for application to living tissue are provided.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: June 15, 2021
    Assignee: STRATEGIC MEDICAL SOLUTIONS, LLC.
    Inventors: Seth McCullen, David Ingram, Michael Aaron Vaughn, William Thomas Stephens, Jr., Melissa Vinci-Rainis, Robert Laudadio
  • Publication number: 20200268893
    Abstract: In situ gel-forming compositions are disclosed, which may comprise one or more absorbable polymers, solvents such as N-methyl-2-pyrrolidone, polyethylene glycol or DMSO, and one or more bioactive agents. The composition forms a hydrogel or semi-solid mass on contact with an aqueous environment. Methods of using in situ gel-forming composition for various applications are also disclosed.
    Type: Application
    Filed: June 29, 2018
    Publication date: August 27, 2020
    Inventors: David Ingram, Michael Aaron Vaughn, Michael Scott Taylor, Kara Bethany Acampora, David Gravett
  • Publication number: 20200238349
    Abstract: A process for immobilizing hazardous waste includes mixing the hazardous waste with a non-swelling clay, a cementitious binder and, optionally, water, and allowing the resulting mixture to set to an immobilized waste material. The process can also include dispersing the hazardous waste in the non-swelling clay to form a dry mixture, mixing the cementitious binder and, optionally, water with the dry mixture to produce a plastic mixture, and allowing the plastic mixture to set to the immobilized waste material.
    Type: Application
    Filed: October 17, 2018
    Publication date: July 30, 2020
    Inventors: Michael David Ingram, Lincoln Morton
  • Publication number: 20190063669
    Abstract: A gantry-type positioning device includes first and second cross members. Two linear guides are disposed parallel to each other on a base and support the first and second cross members such that the cross members are movable in a first direction. A Y-carriage has a functional element and is supported on the first cross member such that the Y-carriage and the functional element are movable in a second direction. A position-measuring device is disposed on the second cross member and the Y-carriage such that a position of the Y-carriage relative to the second cross member is detectable. A Z-carriage supports the functional element such that the functional element is movable relative to the Y-carriage in a third direction. A further position-measuring device is disposed on the Y-carriage and the functional element such that a position of the functional element relative to the Y-carriage is detectable.
    Type: Application
    Filed: August 8, 2018
    Publication date: February 28, 2019
    Inventors: David Ingram, Laurent Heiniger
  • Patent number: 9990694
    Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 5, 2018
    Assignee: Google LLC
    Inventors: Thomas Weedon Hume, Mikkel Crone Köser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
  • Publication number: 20170313808
    Abstract: Bioactive liquid formulations are formed of combinations of absorbable, segmented aliphatic polyurethane compositions and liquid polyether for use as vehicles for the controlled release of at least one active agent for the conventional and unconventional treatment of different forms of cancer and the management of at least one type of bacterial, fungal, and viral infection.
    Type: Application
    Filed: July 17, 2017
    Publication date: November 2, 2017
    Inventors: Shalaby W. Shalaby, Joel T. Corbett, Michael Aaron Vaughn, David Ingram
  • Publication number: 20170086018
    Abstract: A method is provided on a server for controlling messages transmitted to an electronic device. Message preference data is retrieved from a first database. It is then determined if a message is authorised for transmission to the electronic device according to the message preference data, and if the message is determined to be authorised, the message is transmitted from the server to the electronic device. Corresponding devices, systems and computer readable media are also disclosed.
    Type: Application
    Filed: March 3, 2015
    Publication date: March 23, 2017
    Inventors: Daniel Wagner, David Ingram, Michael Johns, Ian Thomas Williamson
  • Publication number: 20170076427
    Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.
    Type: Application
    Filed: November 28, 2016
    Publication date: March 16, 2017
    Inventors: Thomas Weedon Hume, Mikkel Crone Köser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
  • Patent number: 9508172
    Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: November 29, 2016
    Assignee: Google Inc.
    Inventors: Thomas Weedon Hume, Mikkel Crone Koser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
  • Patent number: 9457090
    Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: October 4, 2016
    Assignee: Poly-Med, Inc.
    Inventors: Shalaby W. Shalaby, David Ingram, Georgios Hilas, Sheila Nagatomi
  • Publication number: 20160171486
    Abstract: Devices, systems and methods are disclosed which enable data processing in multiple environments including in electronic transaction type environments, and environments including wireless beacons. In the former, a machine-identifiable tag is utilized to initiate a transaction with an electronic device and various devices and systems supporting such a tag processing platform are described. In the latter, the electronic device can be utilized for configuration and processing of data pertaining to wireless beacons and various systems devices and systems supporting such a wireless beacon environment are described.
    Type: Application
    Filed: July 10, 2014
    Publication date: June 16, 2016
    Inventors: Dan Wagner, David Ingram, Steve Butcher
  • Patent number: 9345704
    Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: May 24, 2016
    Assignee: Indiana University Research and Technology Corporation
    Inventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
  • Publication number: 20150072992
    Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.
    Type: Application
    Filed: November 18, 2014
    Publication date: March 12, 2015
    Inventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
  • Patent number: 8933082
    Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: January 13, 2015
    Assignee: Indiana University Research and Technology Corp.
    Inventors: D Wade Clapp, David Ingram, Feng-Chun Yang
  • Publication number: 20140221922
    Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: POLY-MED, INC.
    Inventors: Shalaby W. Shalaby, David Ingram, Georgios Hilas, Sheila Nagatomi
  • Publication number: 20140121214
    Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.
    Type: Application
    Filed: September 20, 2013
    Publication date: May 1, 2014
    Applicant: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP.
    Inventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
  • Patent number: 8691235
    Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: April 8, 2014
    Assignee: Poly-Med, Inc.
    Inventors: Shalaby W Shalaby, David Ingram, Georgios T Hilas, Sheila Nagatomi
  • Patent number: 8526920
    Abstract: A solution for notifying a user of alternate means of accessing voicemail data utilize a timer that can be set on a user device upon receipt of a message waiting indicator. When the timer expires, if no data communications connection has been established between the user device and a voicemail server, the user device can present alternate voicemail access instructions to the user. These instructions may be obtained from the message waiting indicator or may be stored on the user device. In another embodiment, a voicemail server sets a timer after sending a message waiting indicator to a user device. The voicemail server sends a message containing alternate voicemail access instructions if no connection has been established between the voicemail server and the user device upon expiration of the timer.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: September 3, 2013
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Alison Raphael, David Ingram, Dionne Pignatiello
  • Publication number: 20120238249
    Abstract: A solution for notifying a user of alternate means of accessing voicemail data utilize a timer that can be set on a user device upon receipt of a message waiting indicator. When the timer expires, if no data communications connection has been established between the user device and a voicemail server, the user device can present alternate voicemail access instructions to the user. These instructions may be obtained from the message waiting indicator or may be stored on the user device. In another embodiment, a voicemail server sets a timer after sending a message waiting indicator to a user device. The voicemail server sends a message containing alternate voicemail access instructions if no connection has been established between the voicemail server and the user device upon expiration of the timer.
    Type: Application
    Filed: May 29, 2012
    Publication date: September 20, 2012
    Applicant: AT&T Intellectual Property I, L.P.
    Inventors: Alison Raphael, David Ingram, Dionne Pignatiello